Delivery Order SPE2DB22D3004-SPE2DB25FRD12
- Not listed
- The Defense Logistics Agency awarded a $5,359.81 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This firm fixed-price contract, awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a $5,101.23 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 MG tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a widely used antiemetic medication commonly supplied to military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ondansetron HCL 4 mg tablets (500 tablets) with a ceiling value of $5,367.10. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count) on June 2, 2025, with a ceiling value of $7,959.97 and an ultimate completion date of June 3, 2025. This is a firm fixed price, non-set-aside delivery order to be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a single line item delivery against AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCl 4 mg tablets (30-count packaging) on July 21, 2025, with a ceiling value of $2,110.45 and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ondansetron HCL 4 mg tablets (30-count packaging) with a contract value of $3,436.96. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $2,931.30 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ondansetron HCl 4 mg tablets (500 count). The contract, which is of the firm fixed-price delivery order type with no set-aside designation, represents a competitive award to the pharmaceutical distributor. Performance of this order is scheduled for completion by July 15, 2025, and will be executed at the awardee's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,759.95 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 30, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed from the contractor's facility...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,371.12 to supply Ondansetron HCL 4 mg tablets in a quantity of 30 units. This delivery order, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed-price transaction with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order valued at $5,996.73 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract does not include a set-aside designation. Performance will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRD12Delivery Order
The Defense Logistics Agency awarded a $5,283.82 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count packaging) on June 18, 2025, with completion targeted for June 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. The parent IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical commodities to support Defense Health Agency operations and other federal healthcare customers worldwide. Ondansetron, a common antiemetic medication, aligns with the therapeutic breadth of products AmerisourceBergen routinely delivers through this contract vehicle to support military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 6/18/25 |